Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Over the last 12 months, insiders at Anika Therapeutics, Inc. have bought $0 and sold $0 worth of Anika Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Anika Therapeutics, Inc. have bought $274,901 and sold $1.18M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,500 shares for transaction amount of $32,055 was made by Colleran David (EVP, General Counsel, Corp Sec) on 2022‑05‑11.
2022-05-11 | Colleran David | EVP, General Counsel, Corp Sec | 1,500 0.0104% | $21.37 | $32,055 | +22.64% | ||
2022-03-14 | Colleran David | EVP, General Counsel, Corp Sec | 1,500 0.0109% | $26.65 | $39,978 | -3.85% | ||
2022-03-11 | Blanchard Cheryl R | President, CEO, Director | 3,813 0.0266% | $25.81 | $98,429 | -4.61% | ||
2022-03-11 | Thompson Jeffery S | 2,000 0.0133% | $24.66 | $49,318 | -4.61% | |||
2022-03-11 | Levitz Michael L | EVP, CFO, Treasurer | 4,000 0.0266% | $24.62 | $98,476 | -4.61% | ||
2021-08-12 | Levitz Michael L | EVP, CFO, Treasurer | 777 0.0053% | $40.20 | $31,239 | -23.48% | ||
2021-08-11 | Levitz Michael L | EVP, CFO, Treasurer | 2,850 0.0196% | $40.21 | $114,587 | -22.71% | ||
2021-05-18 | HENNEMAN JOHN B III | director | 2,000 0.014% | $42.86 | $85,720 | -6.92% | ||
2021-05-12 | Sale | LAND RAYMOND J | director | 2,000 0.014% | $42.60 | $85,200 | -5.92% | |
2020-11-10 | Sale | LAND RAYMOND J | director | 3,446 0.0232% | $36.77 | $126,709 | +6.14% | |
2020-07-09 | Sale | Loerop James | EVP Business Development | 1,244 0.0089% | $35.15 | $43,727 | +8.80% | |
2020-02-26 | Sale | LAND RAYMOND J | director | 2,700 0.0192% | $42.68 | $115,236 | -13.87% | |
2019-11-08 | Sale | Cheung Sylvia | Chief Financial Officer | 20,000 0.1389% | $59.71 | $1.19M | -39.44% | |
2019-08-28 | Sale | Larsen Glenn R. | director | 4,355 0.031% | $57.21 | $249,150 | -27.63% | |
2019-08-20 | Sale | Bower Joseph L. | director | 1,994 0.0141% | $55.57 | $110,807 | -24.80% | |
2019-08-08 | Sale | Thompson Jeffery S | director | 4,843 0.0345% | $56.66 | $274,404 | -24.77% | |
2019-07-29 | Sale | LAND RAYMOND J | director | 3,000 0.0222% | $55.44 | $166,320 | -17.75% | |
2019-02-28 | Darling Joseph G | President and CEO; Director | 1,000 0.0072% | $33.20 | $33,200 | +38.89% | ||
2019-02-26 | Sale | LAND RAYMOND J | director | 4,000 0.0287% | $33.06 | $132,240 | +39.32% | |
2017-11-30 | Sale | Hague Richard | Chief Commercial Officer | 5,250 0.0356% | $54.48 | $286,020 | -23.46% |
Fidia Farmaceutici S.p.A. | 10 percent owner | 711192 4.8576% | $25.65 | 0 | 1 | |
SHERWOOD CHARLES H | CEO and Director | 132791 0.907% | $25.65 | 0 | 30 | |
Blanchard Cheryl R | President, CEO, Director | 59992 0.4098% | $25.65 | 1 | 0 | <0.0001% |
WHEELER STEVE E | director | 48219 0.3293% | $25.65 | 0 | 9 | |
Cheung Sylvia | Chief Financial Officer | 47741 0.3261% | $25.65 | 0 | 2 | |
Bower Joseph L. | director | 43010 0.2938% | $25.65 | 0 | 4 | |
DAVIDSON EUGENE A | director | 30000 0.2049% | $25.65 | 0 | 7 | |
QUINLAN KEVIN W | Chief Financial Officer | 27112 0.1852% | $25.65 | 5 | 2 | +3.86% |
Hague Richard | Chief Commercial Officer | 23650 0.1615% | $25.65 | 0 | 1 | |
Darling Joseph G | President and CEO; Director | 22436 0.1532% | $25.65 | 1 | 0 | +38.89% |
Thompson Jeffery S | 17121 0.1169% | $25.65 | 1 | 4 | <0.0001% | |
Levitz Michael L | EVP, CFO, Treasurer | 15924 0.1088% | $25.65 | 3 | 0 | <0.0001% |
Moran John C | director | 14803 0.1011% | $25.65 | 0 | 5 | |
HENNEMAN JOHN B III | director | 11310 0.0772% | $25.65 | 1 | 0 | <0.0001% |
SADOW HARVEY S | director | 10000 0.0683% | $25.65 | 0 | 9 | |
Colleran David | EVP, General Counsel, Corp Sec | 9867 0.0674% | $25.65 | 2 | 0 | +9.4% |
LAND RAYMOND J | director | 7953 0.0543% | $25.65 | 0 | 13 | |
Larsen Glenn R. | director | 7590 0.0518% | $25.65 | 0 | 1 | |
Ahn Edward S. | Chief Tech & Strategy Officer | 7260 0.0496% | $25.65 | 0 | 1 | |
Mrachek William | Vice President, Human Resource | 6854 0.0468% | $25.65 | 2 | 0 | +13.04% |
Loerop James | EVP Business Development | 1756 0.012% | $25.65 | 0 | 1 | |
MCKAY SAMUEL F | director | 0 0% | $25.65 | 0 | 10 | |
LUPPINO FRANCESCO J | Vice President of Operations | 0 0% | $25.65 | 0 | 6 |
Trigran Investments, Inc. | $52.64M | 13.98 | 2.07M | -3.12% | -$1.69M | 5.1 | |
BlackRock | $39.65M | 10.53 | 1.56M | +12.81% | +$4.5M | <0.01 | |
Caligan Partners LP | $36.47M | 9.68 | 1.44M | +32.8% | +$9.01M | 9.64 | |
Dimensional Fund Advisors | $20.57M | 5.46 | 809,755 | -1.42% | -$297,103.80 | 0.01 | |
The Vanguard Group | $19.65M | 5.22 | 773,702 | +1.26% | +$245,287.80 | <0.0001 | |
Morgan Stanley | $17.82M | 4.73 | 701,732 | +44.66% | +$5.5M | <0.01 | |
Renaissance Technologies | $14.22M | 3.78 | 559,817 | -0.8% | -$114,601.96 | 0.02 | |
Boothbay Fund Management LLC | $12.76M | 3.39 | 502,174 | -1.44% | -$186,639.21 | 0.43 | |
Acadian Asset Management | $10.7M | 2.84 | 421,427 | +25.8% | +$2.19M | 0.04 | |
Capital Management Corp Va | $9.25M | 2.46 | 364,025 | +2.39% | +$215,671.40 | 1.82 | |
Geode Capital Management | $8.36M | 2.22 | 329,163 | +3.21% | +$260,379.98 | <0.01 | |
State Street | $8.01M | 2.13 | 315,476 | +2.08% | +$163,448.99 | <0.0001 | |
Alta Fundamental Advisers Llc | $6.64M | 1.76 | 261,382 | +35.75% | +$1.75M | 3.44 | |
Nuveen | $4.98M | 1.32 | 196,176 | -26.1% | -$1.76M | <0.01 | |
Meros Investment Management Lp | $4.32M | 1.15 | 170,127 | +240.6% | +$3.05M | 1.93 | |
D. E. Shaw & Co. | $3.9M | 1.04 | 153,489 | -9.31% | -$400,177.04 | 0.01 | |
Charles Schwab | $3.72M | 0.99 | 146,368 | +23.88% | +$716,559.36 | <0.01 | |
Franklin Templeton Investments | $3.57M | 0.95 | 140,505 | +5.16% | +$175,107.60 | <0.01 | |
Northern Trust | $3.42M | 0.91 | 134,691 | -1.99% | -$69,316.61 | <0.01 | |
Arrowstreet Capital, Limited Partnership | $3.04M | 0.81 | 119,819 | -46.15% | -$2.61M | <0.01 | |
Millennium Management LLC | $2.95M | 0.78 | 116,093 | -64.57% | -$5.37M | <0.01 | |
AQR Capital | $2.52M | 0.67 | 99,301 | +5.47% | +$130,809.98 | <0.01 | |
Deutsche Bank | $2.1M | 0.56 | 82,826 | +0.94% | +$19,558.00 | <0.01 | |
Goldman Sachs | $1.95M | 0.52 | 76,930 | -4.72% | -$96,824.80 | <0.0001 | |
Envestnet Asset Management Inc | $1.92M | 0.51 | 75,740 | -2.77% | -$54,864.00 | <0.01 | |
Two Sigma Advisers LP | $1.82M | 0.48 | 71,583 | +14.93% | +$236,219.97 | <0.01 | |
Allspring Global Investments | $1.66M | 0.44 | 65,270 | +27.95% | +$362,178.60 | <0.01 | |
Stonepine Capital Management Llc | $1.55M | 0.41 | 60,949 | New | +$1.55M | 1.25 | |
Connor Clark & Lunn Investment Management Ltd | $1.53M | 0.41 | 60,084 | +14.14% | +$189,026.85 | <0.01 | |
Diker Management LLC | $1.43M | 0.38 | 56,239 | 0% | +$0 | 1.16 | |
Squarepoint Ops LLC | $1.33M | 0.35 | 52,457 | -10.41% | -$154,889.22 | 0.01 | |
BNY Mellon | $1.3M | 0.34 | 51,041 | -8% | -$112,725.16 | <0.0001 | |
Royal Bank of Canada | $1.22M | 0.32 | 48,112 | -7.83% | -$103,780.60 | <0.0001 | |
Two Sigma | $1.2M | 0.32 | 47,270 | -21.56% | -$330,047.60 | <0.01 | |
Assenagon Asset Management S.A. | $1.19M | 0.32 | 47,012 | -0.03% | -$304.80 | <0.01 | |
Massachusetts Financial Services Co Ma | $1.17M | 0.31 | 46,090 | New | +$1.17M | <0.0001 | |
Virtus Investment Partners | $1.16M | 0.31 | 45,579 | 0% | +$0 | 0.85 | |
Gsa Capital Partners Llp | $1.11M | 0.3 | 43,837 | -24.91% | -$369,138.10 | 0.09 | |
Citadel Advisors LLC | $1.02M | 0.27 | 40,202 | -78.78% | -$3.79M | <0.01 | |
Ameriprise Financial | $1M | 0.27 | 39,524 | -67.89% | -$2.12M | <0.0001 | |
Fisher Asset Management Llc | $980,947.00 | 0.26 | 38,620 | 0% | +$0 | <0.0001 | |
Wellington Management Company | $947,446.00 | 0.25 | 37,301 | New | +$947,446.00 | <0.0001 | |
Invesco | $947,953.00 | 0.25 | 37,321 | +62.92% | +$366,090.05 | <0.0001 | |
Bank of America | $937,742.00 | 0.25 | 36,919 | -34.28% | -$489,051.29 | <0.0001 | |
Trexquant Investment LP | $934,745.00 | 0.25 | 36,801 | -37.05% | -$550,214.56 | 0.01 | |
Tudor Investment Corp Et Al | $915,594.00 | 0.24 | 36,047 | +47.97% | +$296,824.47 | 0.01 | |
Marshall Wace | $871,017.00 | 0.23 | 34,292 | +66.69% | +$348,488.08 | <0.01 | |
GlobeFlex Capital | $816,229.00 | 0.22 | 32,135 | -9.48% | -$85,471.00 | 0.08 | |
Ziegler FAMCO Hedged Equity Fund | $760,552.00 | 0.2 | 29,943 | +5.37% | +$38,760.39 | <0.01 | |
SEI Investments Company | $744,677.00 | 0.2 | 29,318 | 0% | +$0 | <0.01 |